Daiichi Sankyo is a global pharmaceutical company that focuses on the research, development, and commercialization of innovative medicines. With a rich history dating back to 1899, the company is headquartered in Tokyo, Japan, and operates in more than 20 countries worldwide.

Sustainability at Daiichi Sankyo:

• Daiichi Sankyo is committed to sustainability and has integrated environmental, social, and governance (ESG) factors into its business strategy.
• The company publishes an annual ESG report that outlines its efforts and progress in reducing its carbon footprint, promoting diversity and inclusion, and ensuring ethical business practices.
• Daiichi Sankyo has received several sustainability certifications, including ISO 14001 for environmental management systems.
• They have set ambitious targets to reduce greenhouse gas emissions and increase the use of renewable energy sources in their operations.
• However, detailed carbon footprint calculations and specific sustainability metrics are not extensively available in public resources.